Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ClinipharTSE:432A 20 OCF Yield % is 19.25 as of Jul. 15, 2026, which is 189% above its 10-year median of 6.65. GuruFocus rates TSE:432A with a GF Score™ of 20/100. The stock has 3 warning signs investors should review.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Cliniphar OCF Yield % Related Terms
Cliniphar OCF Yield % Historical Data
* Premium members only.
The historical data trend for Cliniphar's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cliniphar OCF Yield % Chart
Cliniphar Annual Data
Trend
Mar24
Mar25
Mar26
OCF Yield %
0.00
0.00
19.25
Cliniphar Semi-Annual Data
Mar24
Mar25
Mar26
OCF Yield %
0.00
0.00
19.25
Cliniphar OCF Yield % Competitor Comparison
For the Pharmaceutical Retailers subindustry, Cliniphar's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cliniphar OCF Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Cliniphar's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Cliniphar's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cliniphar (TSE:432A) has a OCF Yield % of 19.25 as of Jul. 15, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Cliniphar and its competitors. This is 189% above median its historical median of 6.65. Over the past decade, Cliniphar's OCF Yield % has ranged from 6.65 to 19.25.
Is Cliniphar's OCF Yield % too high?
Cliniphar's current OCF Yield % of 19.25 is 189% above median its 10-year median of 6.65. Over the past 10 years, this metric has ranged from a low of 6.65 to a high of 19.25. The Healthcare Providers & Services industry median OCF Yield % is 5.48. Cliniphar's value of 19.25 is 251.3% above this industry median. Overall, Cliniphar has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Cliniphar's OCF Yield % compare to competitors?
Cliniphar's OCF Yield % of 19.25 can be compared against companies in the Healthcare Providers & Services industry. The industry median OCF Yield % is 5.48. Cliniphar's value of 19.25 is 251.3% above this benchmark. Historically, Cliniphar's own OCF Yield % has ranged from 6.65 to 19.25 over the past decade. While the company's 10-year median is 6.65 vs. the industry median of 5.48, Cliniphar has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Healthcare Providers & Services company?
The median OCF Yield % among Healthcare Providers & Services companies is 5.48, based on 686 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cliniphar's current OCF Yield % of 19.25 is 251.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Cliniphar and its competitors. For the Healthcare Providers & Services industry, the median OCF Yield % is 5.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cliniphar's current OCF Yield % is 19.25, which is 189% above median its own 10-year median of 6.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cliniphar stock overvalued right now?
Cliniphar (TSE:432A) has a current OCF Yield % of 19.25. The current OCF Yield % is 19.25, which is 189% above median its 10-year median of 6.65 and 251.3% above the Healthcare Providers & Services industry median of 5.48. Cliniphar's overall GF Score™ is 20/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Cliniphar (TSE:432A), the current OCF Yield % is 19.25 as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:432A has been successfully added to your 
